Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Remeditex Ventures: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Remeditex Ventures
Remeditex Ventures
Active
Website
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Sep 18, 2017
Rodin Therapeutics
$27.0M Other Equity
—
Bruce Booth
, Ben Robbins
, Clay B. Thorp
, John Creecy
, Jason Hong
Jul 1, 2017
VYNE Therapeutics
$51.0M Series C
—
venBio
, Aisling Capital
,
Bay City Capital
, F-Prime Capital
, Novo Holdings
,
Presidio Partners
,
Rock Springs Capital
,
Vivo Capital
Sep 1, 2016
Peloton Therapeutics
$52.0M Series D
Jim Tananbaum
The Column Group
, Nextech Invest
,
Tichenor Ventures
,
Topspin Fund
Dec 1, 2015
Navitor Pharmaceuticals
$33.0M Series B
Vinzenz Ploerer
Endeavor Venture Funds
,
Polaris Partners
,
Venrock
,
Atlas Venture
, Johnson & Johnson Innovation
,
Polaris Partners
, Barry Burgdorf
,
Sanofi Ventures
,
SR One
Nov 1, 2015
Viridian Therapeutics
$41.0M Series C
Jafco Ventures
, Joshua Resnick
Atlas Venture
,
MPM Capital
,
Amgen Ventures
,
Boulder Ventures
,
Brace Pharma Capital
, MP Healthcare Venture Management
Oct 7, 2015
Quartet Medicine
$6.3M Series A Extension
John Creecy
—
Aug 27, 2014
Bellicum Pharmaceuticals
$55.0M Series C
—
AJU IB Investment
,
AVG Ventures
,
Jennison Associates
, Joseph Edelman
, RA Capital Management
,
Redmile Group
,
Ridgeback Capital Investments
,
Sabby Capital
Jan 7, 2014
Bellicum Pharmaceuticals
$14.7M Series B Extension
—
AVG Ventures
Sep 8, 2012
Bi02 Medical
$12.0M Series C
Remeditex Ventures
—
Apr 1, 2012
Viridian Therapeutics
$20.0M Series B
John Creecy
Atlas Venture
,
Broadview Ventures
,
MPM Capital
,
Amgen Ventures
,
Boulder Ventures
,
Broadview Ventures
Mar 8, 2012
Bellicum Pharmaceuticals
$20.0M Series B
—
James Earl "Jim" Brown III
,
AVG Ventures
, Dennis Stone
Jul 1, 2011
Peloton Therapeutics
$18.0M Series A
The Column Group
John Creecy